This finding supported by a previous study and indicated that KRAS mutation is not necessary for β-catenin activation in APC-familiar adenomatous polyposis (FAP)-associated adenomas [3], but synergistically promotes APC loss-induced tumor progression in colorectal cancer [4]. The gene discussed is APC; the disease is neoplasm.